MAI Capital Management - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 83 filers reported holding SEELOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,072
-99.7%
16,695
-98.0%
0.00%
-100.0%
Q2 2023$1,017,425
+58.7%
851,402
-8.2%
0.02%
+50.0%
Q1 2023$641,034
-7.6%
927,422
-9.3%
0.01%
-16.7%
Q4 2022$693,943
-45.3%
1,022,008
-17.0%
0.01%
-50.0%
Q3 2022$1,268,000
+267.5%
1,230,810
+142.6%
0.02%
+242.9%
Q2 2022$345,000507,4160.01%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders